Is Corcept Therapeutics (CORT) a Solid Value Investors Stock? Posted byZacks Equity Research January 31, 2022 Leave a comment on Is Corcept Therapeutics (CORT) a Solid Value Investors Stock? Let’s see if Corcept Therapeutics (CORT) stock is a good choice for value-oriented investors right now from multiple angles.